GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
18.15
-0.66 (-3.51%)
At close: Oct 16, 2026, 4:00 PM EDT
18.47
+0.32 (1.76%)
Pre-market: Oct 19, 2026, 7:42 AM EDT
GH Research Earnings Call Transcripts
Fiscal Year 2025
-
GH001 showed rapid, robust, and sustained efficacy in TRD, with a high remission rate and favorable safety profile. Long-term data indicate durable remission with infrequent treatments and fewer clinic visits compared to current standards.